Anlotinib Combined with Osimertinib Reverses Acquired Osimertinib Resistance in NSCLC by Targeting the c-MET/MYC/AXL Axis

被引：0
|
作者：
Lei, T. [1 ]
Xu, T. [2 ]
Zhang, N. [1 ]
Zou, X. [1 ]
Wei, C. [1 ]
Wang, Z. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Peoples R China
[2] Nanjing Med Univ, Nanjing Hosp 1, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Anlotinib; Osimertinib resistance; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-70
引用
收藏
页码：S670 / S670
页数：1
相关论文
共 34 条
  • [21] Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer
    Chu, Yu-Yi
    Yam, Clinton
    Chen, Mei-Kuang
    Chan, Li-Chuan
    Xiao, Min
    Wei, Yong-Kun
    Yamaguchi, Hirohito
    Lee, Pei-Chih
    Han, Ye
    Nie, Lei
    Sun, Xian
    Moulder, Stacy L.
    Hess, Kenneth R.
    Wang, Bin
    Hsu, Jennifer L.
    Hortobagyi, Gabriel N.
    Litton, Jennifer
    Chang, Jeffrey T.
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (02): : 648 - 661
  • [22] Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report
    Zhou, Rengui
    Song, Lei
    Zhang, Wenwen
    Shao, Lin
    Li, Xi
    Li, Xiangyong
    ONCOTARGETS AND THERAPY, 2021, 14 : 2847 - 2851
  • [23] Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway
    Huang, Guodong
    Liu, Xinning
    Jiang, Ting
    Cao, Yufeng
    Sang, Mingyu
    Song, Xiaomeng
    Zhou, Baochen
    Qu, Honglin
    Cai, Houhao
    Xing, Daijun
    Mao, Yuecheng
    Lin, Gaoyang
    Liu, Xiantao
    Zheng, Xin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 4145 - 4162
  • [24] Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC
    Minari, Roberta
    Bordi, Paola
    La Monica, Silvia
    Squadrilli, Anna
    Leonetti, Alessandro
    Bottarelli, Lorena
    Azzoni, Cinzia
    Lagrasta, Costanza Anna Maria
    Gnetti, Letizia
    Campanini, Nicoletta
    Petronini, Pier Giorgio
    Alfieri, Roberta
    Tiseo, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : E89 - E91
  • [25] Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway
    Tang, Xia-li
    Yan, Li
    Zhu, Ling
    Jiao, De-min
    Chen, Jun
    Chen, Qing-yong
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 135 (01) : 1 - 7
  • [26] INSIGHT 2: Tepotinib plus osimertinib in patients with EGFR-mutant NSCLC having acquired resistance to EGFR TKIs due to MET-amplification: A phase II trial in progress study
    Yang, J. C-H.
    Ellers-Lenz, B.
    Straub, J.
    Johne, A.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Effects of Ephedra Herb extract on the expression of EGFR-activating mutations and c-Met in non-small-cell lung cancer cell line, H1975, and its combined effects with osimertinib
    Eiko Mori
    Sumiko Hyuga
    Toshihiko Hanawa
    Katsuhiko Naoki
    Hiroshi Odaguchi
    Journal of Natural Medicines, 2023, 77 : 523 - 534
  • [28] Effects of Ephedra Herb extract on the expression of EGFR-activating mutations and c-Met in non-small-cell lung cancer cell line, H1975, and its combined effects with osimertinib
    Mori, Eiko
    Hyuga, Sumiko
    Hanawa, Toshihiko
    Naoki, Katsuhiko
    Odaguchi, Hiroshi
    JOURNAL OF NATURAL MEDICINES, 2023, 77 (03) : 523 - 534
  • [29] Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis
    Yuan Sun
    Yoshihide Fujigaki
    Masanori Sakakima
    Tomoyuki Fujikura
    Akashi Togawa
    Yanjie Huang
    Akira Hishida
    Clinical and Experimental Nephrology, 2011, 15 : 666 - 675
  • [30] Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis
    Sun, Yuan
    Fujigaki, Yoshihide
    Sakakima, Masanori
    Fujikura, Tomoyuki
    Togawa, Akashi
    Huang, Yanjie
    Hishida, Akira
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (05) : 666 - 675
1234